Biometric Integration
Recovery lives in the trajectory, not the snapshot. Tattva continuously tracks metrics such as heart rate, sleep, and activity - turning raw data into a readable arc of progress.
Tattva integrates five disciplines that are rarely combined in cardiovascular care:
Tattva was founded by Simran Kaur and Ish Kaur — a team that bridges venture capital, biotech strategy and evidence-based cardiovascular innovation.
Brings over 15 years of experience in biotech, diagnostics, and AI-enabled cardiovascular innovation. Her work spans FDA-approved cancer diagnostics at Foundation Medicine, AI-powered ECG algorithms developed in collaboration with Mayo Clinic at Anumana, and targeted therapies for complex diseases.
Across these efforts, she repeatedly observed a pattern often overlooked in modern cardiology: the powerful role of stress physiology and autonomic nervous system regulation in shaping long-term cardiovascular outcomes — particularly among high-performing midlife individuals.
That insight became the founding thesis behind Tattva Health.
Brings over eight years of experience at the intersection of capital, innovation, and emerging technology. Her career spans Wall Street and venture capital, where she became one of the youngest Directors of Innovation, evaluating and scaling frontier technology ventures across sectors including cleantech, sustainable infrastructure, and digital health.
Through this work, she developed deep expertise in financial strategy, commercial architecture, and the operational mechanics required to transform early innovation into scalable companies.
At Tattva Health, Ish leads strategy, operations, and commercial development, applying the rigor of venture capital and the discipline of financial modeling to build a platform that is both clinically credible and commercially viable. Her focus is ensuring that Tattva’s Cardiac Recovery & Resilience Intelligence Platform can integrate into existing healthcare infrastructure while scaling to reach individuals and health systems globally.
Tattva is advised by cardiologists and researchers with deep expertise in cardiovascular medicine, HRV science, and behavioral health.
Dr. Rupal Patel is a leading expert in voice science, artificial intelligence, and human-centered health technology, with more than two decades of experience translating speech and communication research into real-world clinical and commercial applications.
She is a tenured professor at Northeastern University, with joint appointments in the Bouve College of Health Sciences and the Khoury College of Computer Sciences, where she has founded and led multiple interdisciplinary research initiatives focused on speech, voice, and health — including the Voice of Women (VOxx) Lab and the ASTRiC Center for Applied Speech Technology Innovation.
Dr. Patel is also the founder and former CEO of VocaliD, a pioneering Voice AI company that developed personalized synthetic voices for individuals and brands. VocaliD was acquired by Veritone in 2022, where she served as Vice President of Voice AI and Accessibility, advancing the application of generative AI across healthcare, media, and regulated industries.
She has been recognized as one of Fast Company’s “100 Most Creative People in Business” and is widely regarded as a thought leader in ethical and applied AI. At Tattva Health, Dr. Patel guides the development of voice as a measurable signal within a multimodal recovery intelligence platform.
Dr. Robert C. Rollings is a board-certified cardiologist with more than three decades of clinical and academic experience spanning cardiovascular imaging, preventive cardiology, and cardiac rehabilitation.
A graduate of Vanderbilt University School of Medicine, Dr. Rollings completed his cardiology fellowship at the University of Vermont and has held numerous leadership roles across cardiovascular medicine throughout his career. He is a Fellow of the American College of Cardiology (FACC), the American Heart Association (FAHA), the American Society of Echocardiography (FASE), the American Society of Nuclear Cardiology (FASNC), and multiple other major cardiovascular societies, reflecting his deep engagement across the field.
Dr. Rollings has extensive expertise in advanced cardiovascular imaging, including echocardiography, nuclear cardiology, cardiac CT, and cardiac MRI. His work has contributed to clinical research in cardiovascular imaging, autonomic physiology, and cardiometabolic risk, including collaborations with leading academic research groups studying the relationship between stress biology and cardiovascular disease.
Throughout his career, he has been deeply interested in the intersection of cardiovascular physiology, stress biology, and human performance. In addition to traditional cardiology practice, he has pursued advanced training in mind–body medicine, meditation, and breath-based practices, exploring how autonomic regulation and behavioral patterns influence long-term cardiovascular health.
This integrative perspective aligns closely with the mission of Tattva Health: to better understand and support the physiology of cardiac recovery beyond the walls of the clinic.
Dr. Rollings brings to Tattva a rare combination of clinical cardiology expertise, imaging innovation, and insight into the role of stress and nervous system regulation in cardiovascular outcomes, helping guide the development of the company’s Cardiac Recovery & Resilience Intelligence Platform.
The weeks after a cardiac event are the most critical — and the most unsupported. Tattva fills that space with structured, intelligent, continuous care designed to meet patients where they are.
Find out what that looks like for you.